The Greek health minister accused Roche (ROG) of blackmail after the drug maker moved to withdraw a cancer drug from the market in response to mandatory discounts imposed by the government.
As part of a bailout deal with its international lenders, such as the European Central Bank and the International Monetary Fund, the Greek government earlier this year imposed a 25 percent levy on sales generated by new patented medicines. And more recently, another 25 percent levy was added on new medicines.
Given that Novartis owns 1/3 of the voting shares in Roche [albeit ‘only 6% of the stock … somehow?], does that mean one should say another pharma is already ‘following suit’? Or not, of course ……
Comments are closed.